Cargando…

Comparative cost analysis of implanting devices in different cardiac resynchronization therapeutic strategies

BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment option for heart failure patients. However, the implementation of triple‐chamber pacemakers can be cost‐prohibitive. His‐Purkinje system pacing (HPSP) can also enable cardiac resynchronization, and it can be achieved wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mengna, Shi, Jing, Zhang, Yimin, Ge, Xiaozhen, Zhang, Xu, Fan, Wenbin, Wang, Shuo, Guo, Zhiqin, Guan, Jian, Wu, Yongquan, Zhang, Junmeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577564/ https://www.ncbi.nlm.nih.gov/pubmed/37537947 http://dx.doi.org/10.1002/clc.24107

Ejemplares similares

Success rates, challenges and troubleshooting of left bundle branch area pacing as a cardiac resynchronization therapy for treating patients with heart failure
por: Zhang, Junmeng, et al.
Publicado: (2023)

Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes
por: Goldstein, Sarah A., et al.
Publicado: (2018)

Cardiac resynchronization performed by LBBaP‐CRT in patients with cardiac insufficiency and left bundle branch block
por: Zu, Linna, et al.
Publicado: (2021)

Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II
por: Koçyiğit, Duygu, et al.
Publicado: (2020)

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK
por: Burri, Haran, et al.
Publicado: (2013)

Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
por: Arai, Shuhei, et al.
Publicado: (2020)

Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators
por: Kawamura, Mitsuharu, et al.
Publicado: (2019)

Timing of cardiac resynchronization therapy implantation
por: Leyva, Francisco, et al.
Publicado: (2023)

Improvement in left ventricular intrinsic dyssynchrony with cardiac resynchronization therapy
por: Bozyel, Serdar, et al.
Publicado: (2017)

Pectoral nerves (PECS) and intercostal nerve block for cardiac resynchronization therapy device implantation
por: Fujiwara, Atsushi, et al.
Publicado: (2014)

Utility of 3-D printing for cardiac resynchronization device implantation in congenital heart disease
por: Kanawati, Juliana, et al.
Publicado: (2020)

Epicardial left ventricular lead implantation in cardiac resynchronization therapy patients via a video‐assisted thoracoscopic technique: Long‐term outcome
por: Marini, Massimiliano, et al.
Publicado: (2019)

Cardiac resynchronization in the elderly is beneficial, but could we implant our devices in old patients safer?
por: Mikhaylov, Evgeny N, et al.
Publicado: (2016)

Triple lead cephalic versus subclavian vein approach in cardiac resynchronization therapy device implantation
por: Vogler, Julia, et al.
Publicado: (2018)

Cardiac Resynchronization Therapy Device Implantation in a Patient with Congenitally Corrected Transposition of Great Vessels
por: Mollazadeh, Reza, et al.
Publicado: (2017)

Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation
por: Roukoz, Henri, et al.
Publicado: (2020)

Trends in the Use and Complications of Cardiac Resynchronization Therapy Device Implantation in Chronic Kidney Disease Patients
por: Kichloo, Asim, et al.
Publicado: (2023)

Device runtime and costs of cardiac resynchronization therapy pacemakers – a health claims data analysis
por: Hadwiger, Moritz, et al.
Publicado: (2022)

Mitral Annuloplasty Using a Cardiac Resynchronization Device
por: Manzoor Ali, Andrabi Syed, et al.
Publicado: (2010)

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation
por: Black‐Maier, Eric, et al.
Publicado: (2017)

Left ventricular‐only fusion pacing versus cardiac resynchronization therapy in heart failure patients: A randomized controlled trial
por: Su, Yangang, et al.
Publicado: (2021)

Intracardiac Thrombosis and Heart Failure in a Patient with Hepatocellular Carcinoma and Cardiac Amyloidosis and an Implanted Cardiac Resynchronization Therapy Device
por: Akutsu, Yasushi, et al.
Publicado: (2019)

Go for the right left ventricular lead position at initial implantation of a cardiac resynchronization therapy device
por: Fyenbo, Daniel Benjamin, et al.
Publicado: (2022)

Trends in the use of implantable cardioverter‐defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2020)

Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events
por: Szepietowska, Barbara, et al.
Publicado: (2016)

Surface electrogram-guided left ventricular lead placement improves response to cardiac resynchronization therapy
por: Şipal, Abdulcebbar, et al.
Publicado: (2018)

Estimated Cost of Developing a Therapeutic Complex Medical Device in the US
por: Sertkaya, Aylin, et al.
Publicado: (2022)

Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
por: Borne, Ryan T., et al.
Publicado: (2021)

Safe application of extensive radiotherapy to a cardiac resynchronization device
por: Schernthaner, Christiana, et al.
Publicado: (2020)

The impact of the left ventricular pacing polarity and localization during cardiac resynchronization therapy on depolarization and repolarization parameters
por: Özcan, Emin Evren, et al.
Publicado: (2018)

Thoracoscopic Left Ventricular Lead Implantation in Cardiac Resynchronization Therapy
por: Jeong, Dong Seop, et al.
Publicado: (2012)

Mid-Term Outcomes in Patients Implanted with Cardiac Resynchronization Therapy
por: Lee, Sung Ho, et al.
Publicado: (2014)

Pneumopericardium and Pneumomediastinum After Implantation of a Cardiac Resynchronization Pacemaker
por: Green, Peregrine G., et al.
Publicado: (2019)

Anatomy of the coronary sinus with regard to cardiac resynchronization therapy implantation
por: Borgquist, Rasmus, et al.
Publicado: (2022)

Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support
por: Lim, Kyunghee, et al.
Publicado: (2017)

Cardiac resynchronization therapy device implantation guided by electroanatomic mapping system when contrast medium infusion is contraindicated
por: Calzolari, Vittorio, et al.
Publicado: (2016)

PO-02-028 NEGATIVE EFFECTS OF COVID-19 ON THE IMPLANTATION RATE OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR DEVICE.
por: Udongwo, Ndausung, et al.
Publicado: (2023)

Single center experience with subcutaneous ICD in combination with previously implanted endocardial or epicardial antibradycardia or cardiac resynchronization devices
por: Som, Z, et al.
Publicado: (2023)

Zero‐fluoroscopy transseptal puncture guided by right atrial electroanatomical mapping combined with intracardiac echocardiography: A single‐center experience
por: Zhang, Guangping, et al.
Publicado: (2020)

Cardiac resynchronization therapy improved the clinical outcomes in pacemaker patients upgraded to biventricular device
por: Jin, Han, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mi84m61nm2c5ohtb5vt0sam3ed